2001
DOI: 10.4049/jimmunol.167.9.5231
|View full text |Cite
|
Sign up to set email alerts
|

Escherichia coliBraun Lipoprotein Induces a Lipopolysaccharide-Like Endotoxic Response from Primary Human Endothelial Cells

Abstract: All bacteria contain proteins in which their amino-terminal cysteine residue is modified with N-acyl S-diacylglycerol functions, and peptides and proteins bearing this modification are immunomodulatory. The major outer membrane lipoprotein of Escherichia coli, the Braun lipoprotein (BLP), is the prototypical triacylated cysteinyl-modified protein. We find it is as active as LPS in stimulating human endothelial cells to an inflammatory phenotype, and a BLP-negative mutant of E. coli was less inflammatory than i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
38
0
3

Year Published

2003
2003
2016
2016

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(41 citation statements)
references
References 59 publications
(36 reference statements)
0
38
0
3
Order By: Relevance
“…LPS, but Not an Endotoxic Lipopeptide, Desensitized Endothelial Cells to Commercial Ovalbumin-We explored the nature of the inflammatory agent in commercial ovalbumin by distinguishing LPS from non-LPS endotoxins, because both prokaryotic proteins displaying a lipid-modified N-terminal cysteinyl residue and LPS are a potent endothelial cell agonists (26,27). We selectively desensitized endothelial cells to either LPS or endotoxic proteins by a 24-h pre-exposure to Salmonella LPS or a synthetic lipid-modified endotoxic peptide Pam 3 CSK 4 .…”
Section: Lps From S Minnesota Is Resistant To Polymyxin B Sequestratmentioning
confidence: 99%
“…LPS, but Not an Endotoxic Lipopeptide, Desensitized Endothelial Cells to Commercial Ovalbumin-We explored the nature of the inflammatory agent in commercial ovalbumin by distinguishing LPS from non-LPS endotoxins, because both prokaryotic proteins displaying a lipid-modified N-terminal cysteinyl residue and LPS are a potent endothelial cell agonists (26,27). We selectively desensitized endothelial cells to either LPS or endotoxic proteins by a 24-h pre-exposure to Salmonella LPS or a synthetic lipid-modified endotoxic peptide Pam 3 CSK 4 .…”
Section: Lps From S Minnesota Is Resistant To Polymyxin B Sequestratmentioning
confidence: 99%
“…Similarly, both Lpp and LPS activate the complement cascade, coagulation cascade, and other inflammatory mediators (24)(25)(26)(27). In addition, Lpp purified from Y. enterocolitica synergizes with its LPS to induce production of proinflammatory cytokines in vitro and in vivo, leading to septic shock (28).…”
mentioning
confidence: 99%
“…In addition, Lpp purified from Y. enterocolitica synergizes with its LPS to induce production of proinflammatory cytokines in vitro and in vivo, leading to septic shock (28). Lpp binds to TLR-2 to activate host cells (27,29), while LPS interacts with a host cell receptor complex consisting of TLR-4 and its coreceptor, myeloid differentiation protein 2 (MD-2), to induce cellular responses (30)(31)(32)(33)(34)(35).…”
mentioning
confidence: 99%
“…One obvious difference among various hosts is within the amino acid sequences of the complement proteins. For example, FH consists of 20 short consensus repeat (SCR) domains (28), and Ail is predicted to bind FH near SCR7 (12)(13)(14). Mouse SCR6-8 has 55% identity and 70% homology with human SCR6-8 (29), indicating that differences in this region of FH may influence interactions with Ail.…”
Section: Discussionmentioning
confidence: 99%
“…Both Lpp and LPS trigger toxic and biological responses in the hosts through the interaction of their lipid domains with Toll-like receptor 2 (TLR-2) and TLR-4, respectively, and by evoking the production of inflammatory cytokines such as tumor necrosis factor (TNF-␣), interleukin 6 (IL-6), and inter-feron gamma (IFN-␥) (14,15). Also, the complement and coagulation cascades are activated by both Lpp and LPS, and the production of other damaging inflammatory mediators contributes to the severity of infection (14,(16)(17)(18).…”
mentioning
confidence: 99%